EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 199 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 101 | -35.7% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 157 | -30.8% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 227 | -6.6% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 243 | +21.5% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 200 | -5.7% | 0.00% | – |
| Q2 2021 | $13,000 | -27.8% | 212 | +6.0% | 0.00% | – |
| Q1 2021 | $18,000 | -74.6% | 200 | -75.0% | 0.00% | -100.0% |
| Q4 2020 | $71,000 | -24.5% | 800 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $94,000 | +23.7% | 919 | -4.6% | 0.00% | 0.0% |
| Q2 2020 | $76,000 | +192.3% | 963 | +112.6% | 0.00% | – |
| Q1 2020 | $26,000 | +136.4% | 453 | +112.7% | 0.00% | – |
| Q4 2019 | $11,000 | 0.0% | 213 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | 0.0% | 213 | -6.2% | 0.00% | – |
| Q2 2019 | $11,000 | -38.9% | 227 | -37.5% | 0.00% | – |
| Q1 2019 | $18,000 | – | 363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |